Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections

R Sirijatuphat, V Thamlikitkul - Antimicrobial agents and …, 2014 - Am Soc Microbiol
Ninety-four patients infected with carbapenem-resistant Acinetobacter baumannii were
randomized to receive colistin alone or colistin plus fosfomycin for 7 to 14 days. The patients …

Multidrug resistance Acinetobacter bacteremia secondary to ventilator-associated pneumonia: risk factors and outcome

E Brotfain, A Borer, L Koyfman… - Journal of intensive …, 2017 - journals.sagepub.com
Purpose: Acinetobacter baumannii is a multidrug resistant (MDR), gram-negative bacterium
commonly implicated in ventilator-associated pneumonia (VAP) in critically ill patients …

[HTML][HTML] Prognostic risk factors in ventilator-associated pneumonia

Z Karakuzu, R Iscimen, H Akalin, NK Girgin… - … Medical Journal of …, 2018 - ncbi.nlm.nih.gov
Prognostic Risk Factors in Ventilator-Associated Pneumonia - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle

V Zaydfudim, LA Dossett, JM Starmer… - Archives of …, 2009 - jamanetwork.com
Background Ventilator-associated pneumonia (VAP) causes significant morbidity and
mortality in critically ill surgical patients. Recent studies suggest that the success of …

Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU

M Esperatti, M Ferrer, V Giunta, OT Ranzani… - Critical care …, 2013 - journals.lww.com
Objective: To validate a set of predictors of adverse outcomes in patients with ICU-acquired
pneumonia in relation to clinically relevant assessment at 28 days. Design: Prospective …

Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality

C Peña, S Gómez-Zorrilla, I Oriol, F Tubau… - European journal of …, 2013 - Springer
The prevalence of multidrug-resistant (MDR) Pseudomonas aeruginosa has increased over
the past decade and a significant rise in these isolates in ventilator-associated pneumonia …

[PDF][PDF] An early predictor of the outcome of patients with ventilator-associated pneumonia

KT Huang, CC Tseng, WF Fang, MC Lin - Chang Gung Med J, 2010 - cgmj.cgu.edu.tw
Background: Ventilator-associated pneumonia (VAP) contributes to high mortality,
prolonged intensive care unit (ICU) stay and increased costs of health care. Reports of early …

Association between systemic corticosteroids and outcomes of intensive care unit–acquired pneumonia

OT Ranzani, M Ferrer, M Esperatti, V Giunta… - Critical care …, 2012 - journals.lww.com
Objective: The use of corticosteroids is frequent in critically-ill patients. However, little
information is available on their effects in patients with intensive care unit–acquired …

Hospital-acquired pneumonia developed in non-intensive care units

E Cakir Edis, ON Hatipoglu, I Yilmam, A Eker, O Tansel… - Respiration, 2009 - karger.com
Background: There are few studies about hospital-acquired pneumonia (HAP) developing in
non-intensive care units (non-ICUs). Objectives: The aim of this study was to determine the …

集束化治疗颅脑疾病呼吸机相关性肺炎的临床观察

刘向东, 蒲运刚, 于湘友, 于朝霞 - 中国中西医结合急救杂志, 2011 - cqvip.com
目的探讨集柬化(Bundle) 治疗对重症监护病房(ICU) 重型颅脑疾病患者呼吸机相关性肺炎(VAP)
的临床疗效. 方法采用前瞻性随机对照试验, 选择2009 年3 月1 日至2011 年7 月1 日入住ICU …